UK markets close in 5 hours 27 minutes

PharmaEngine, Inc. (4162.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
94.90+1.20 (+1.28%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 13.46B
Enterprise value 9.77B
Trailing P/E 49.06
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)17.65
Price/book (mrq)3.41
Enterprise value/revenue 12.78
Enterprise value/EBITDA 28.09

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-7.68%
S&P500 52-week change 323.57%
52-week high 3122.50
52-week low 379.80
50-day moving average 396.85
200-day moving average 396.33

Share statistics

Avg vol (3-month) 31.07M
Avg vol (10-day) 3465.2k
Shares outstanding 5143.68M
Implied shares outstanding 6151.1M
Float 893.31M
% held by insiders 120.18%
% held by institutions 121.83%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42
Forward annual dividend yield 42.13%
Trailing annual dividend rate 31.50
Trailing annual dividend yield 31.60%
5-year average dividend yield 42.04
Payout ratio 4104.71%
Dividend date 3N/A
Ex-dividend date 415 Aug 2023
Last split factor 21199.953:1000
Last split date 326 Jul 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 35.78%
Operating margin (ttm)34.79%

Management effectiveness

Return on assets (ttm)4.37%
Return on equity (ttm)7.10%

Income statement

Revenue (ttm)767.67M
Revenue per share (ttm)5.35
Quarterly revenue growth (yoy)18.20%
Gross profit (ttm)N/A
EBITDA 278.55M
Net income avi to common (ttm)274.65M
Diluted EPS (ttm)1.91
Quarterly earnings growth (yoy)-30.30%

Balance sheet

Total cash (mrq)3.63B
Total cash per share (mrq)25.25
Total debt (mrq)14.81M
Total debt/equity (mrq)0.38%
Current ratio (mrq)46.78
Book value per share (mrq)26.89

Cash flow statement

Operating cash flow (ttm)256.97M
Levered free cash flow (ttm)159.87M